Influenza News and Research

Latest Influenza News and Research

Could CRISPR be used as a SARS-CoV-2 antiviral?

The potential of using this gene manipulation technology as a SARS-CoV-2 inhibitor or prophylactic is investigated in a review recently uploaded to the journal Experimental Biology and Medicine (April 25th, 2021) by Arnab Banerjee and colleagues.

2 May 2021

Study implies a likely rise of future SARS-CoV-2 recombinants

A recent astonishing feat by US researchers revealed that recombination is not only widespread in the evolutionary history of SARS-like coronaviruses, but it can also increase fitness traits of seasonal coronaviruses. Their paper is currently available on the bioRxiv* preprint server and sets the stage for phylogenetic tracking of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

2 May 2021

Live "attenuated" influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2

Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).

2 May 2021

Vaccines can save lives and safeguard health and well-being

Effectively and safely protecting against disease--this is what makes vaccines a vital and successful public health tool that saves lives and safeguards health and well-being. Today, vaccines shield us from more than 20 life-threatening diseases.

30 Apr 2021

Furin cleavage site crucial in SARS-CoV-2 for viral transmission in ferrets, finds study

Researchers based at Imperial College London, UK, have recently highlighted the effects of these deleterious CS mutations through a ferret animal model, demonstrating that furin cleavage sites are a necessary component in the virus’ ability to replicate.

30 Apr 2021

Despite all the talk, Covid vaccination does not infect people with shingles

Posts are showing up all over social media tying Covid-19 vaccinations to shingles and other painful skin disorders.

30 Apr 2021

Study highlights significant gap in evidence related to effectiveness of portable air filters in reducing COVID-19

Considerable gap in evidence around whether portable air filters reduce the incidence of COVID-19 and other respiratory infections.

30 Apr 2021

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Children and young adults with compromised immune systems, such as those undergoing cancer treatment, may experience a prolonged period of infection with SARS-CoV-2, the virus that causes COVID-19, and the extended duration of infection may increase the incidence of mutations.

29 Apr 2021

Can control theory explain differences in virulence and transmission of SARS-CoV-2?

A new study discusses variations in viral pathogenicity and in transmission, which are responsible for asymptomatic infection and for superspreading events. The ability to understand this would open the way to understand how this virus behaves the way it does, in terms of its virulence, its spread, and its emergent variants of concern.

28 Apr 2021

Eosinophils modify the respiratory barrier during influenza A infection, shows study

For the first time in published literature, Le Bonheur Children's Hospital and University of Tennessee Health Science Center (UTHSC) researchers showed that a variety of white blood cells known as eosinophils modify the respiratory barrier during influenza A (IAV) infection, according to a recent paper in the journal Cells.

28 Apr 2021

SARS-CoV-2 virus neutralized with half-second exposure to very high temperature

As reported in the journal Biotechnology and Bioengineering, the team from Texas A&M University developed a simple fluidics system that measures the sub‐second heat inactivation of coronaviruses.

27 Apr 2021

Heat treatment for less than a second completely inactivates SARS-CoV-2

Arum Han, professor in the Department of Electrical and Computer Engineering at Texas A&M University, and his collaborators have designed an experimental system that shows exposure of SARS-CoV-2 to a very high temperature, even if applied for less than a second, can be sufficient to neutralize the virus so that it can no longer infect another human host.

27 Apr 2021

Influenza News and Research

Latest Influenza News and Research

Could CRISPR be used as a SARS-CoV-2 antiviral?

Study implies a likely rise of future SARS-CoV-2 recombinants

Live "attenuated" influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2

Vaccines can save lives and safeguard health and well-being

Furin cleavage site crucial in SARS-CoV-2 for viral transmission in ferrets, finds study

Despite all the talk, Covid vaccination does not infect people with shingles

Study highlights significant gap in evidence related to effectiveness of portable air filters in reducing COVID-19

Immunocompromised children and young adults may experience prolonged SARS-CoV-2 infection

Can control theory explain differences in virulence and transmission of SARS-CoV-2?

Eosinophils modify the respiratory barrier during influenza A infection, shows study

SARS-CoV-2 virus neutralized with half-second exposure to very high temperature

Heat treatment for less than a second completely inactivates SARS-CoV-2

New treatment reduces the severity of ARDS in influenza-infected mice

SARS-CoV-2 clade linked to disease severity in the early phase of the pandemic

Study uncovers a novel autoantigen in patients with narcolepsy type 1

Host cell transmembrane protein MARCH8 targets lysine residues to inhibit SARS-CoV-2 and other viruses

COVID-19 survivors have increased risk of death for at least six months

Celastrol shows potential anti-SARS-CoV-2 activity

Artificial intelligence helps identify new key-lock pairs against coronavirus

Study investigates the prevalence of COVID-19 symptoms among immunocompromised children

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Influenza News and Research

Latest Influenza News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in